Search

Siobhan P Ellison

from Reddick, FL
Age ~72

Siobhan Ellison Phones & Addresses

  • 15471 NW 112Th Ave, Reddick, FL 32686
  • Fairfield, FL
  • Mc Intosh, FL
  • PO Box 970, Fairfield, FL 32634

Work

Company: Pathogenes inc Position: Ceo

Education

Degree: BS, MS, DVM, PhD School / High School: University of Florida 1973 to 2001 Specialities: Veterinary Medicine, Veterinary Microbiology, Molecular Biology

Skills

Surgery • Equestrian • Veterinary Medicine • Hardware Diagnostics • Biotechnology • Veterinary • Life Sciences • Strategic Planning • Dairy • Dogs • Molecular Biology • New Business Development • Customer Service • Pets • Vaccines • Management • Product Development • Pharmaceutical Industry • Marketing Strategy • Farms

Industries

Veterinary

Resumes

Resumes

Siobhan Ellison Photo 1

Chief Executive Officer Community Pharmacy

View page
Location:
15471 northwest 112Th Ave, Reddick, FL 32686
Industry:
Veterinary
Work:
Pathogenes Inc
CEO
Education:
University of Florida 1973 - 2001
BS, MS, DVM, PhD, Veterinary Medicine, Veterinary Microbiology, Molecular Biology
Skills:
Surgery
Equestrian
Veterinary Medicine
Hardware Diagnostics
Biotechnology
Veterinary
Life Sciences
Strategic Planning
Dairy
Dogs
Molecular Biology
New Business Development
Customer Service
Pets
Vaccines
Management
Product Development
Pharmaceutical Industry
Marketing Strategy
Farms

Business Records

Name / Title
Company / Classification
Phones & Addresses
Siobhan Ellison
President
AFTERMARKET INC
15471 NW 112 Ave, Reddick, FL 32686
Siobhan P. Ellison
Director
Pathogenes Inc
Computer Software · Commercial Physical Research
PO Box 970, Fairfield, FL 32634
15471 NW 112 Ave, Fairfield, FL 32634
(352) 591-3221
Siobhan Ellison
Chief Executive Officer
Aftermarket Pharmaceuticals Inc
Mfg Pharmaceutical Preparations · Pharmaceutical Preparations
15471 NW 112 Ave, Flemington, FL 32686
Siobhan P. Ellison
President, Treasurer, Secretary
SIOBHAN P. ELLISON, D.V.M., PA
15471 NW 112 Ave, Fairfield, FL 32634
Fairfield, FL 32634
PO Box 970, Fairfield, FL 32634

Publications

Us Patents

Detection Of Sarcocystis Neurona

View page
US Patent:
6808714, Oct 26, 2004
Filed:
Sep 24, 2001
Appl. No.:
09/962993
Inventors:
John B. Dame - Gainesville FL
Siobhan P. Ellison - Fairfield FL
Charles A. Yowell - Gainesville FL
Assignee:
University of Florida - Gainesville FL
International Classification:
A61K 39002
US Classification:
4242691, 4242651, 4241921, 4241911, 4241851, 4241841, 4241781, 4241341, 435 697, 435 701, 435 7021, 435 711, 536 234, 514 44
Abstract:
A gene encoding a 29 kilodalton protein found on the surface of merozoite stage has been cloned and sequenced. The protein encoded by this gene, termed SnSAG-1, is an immunodominant antigen recognized on protein blots. Methods for using nucleic acids and polypeptides relating to SnSAG-1 in diagnostic tests and vaccine development are disclosed.

Methods For The In Vitro Culture Of Sp. And Uses Thereof

View page
US Patent:
7250286, Jul 31, 2007
Filed:
May 20, 2003
Appl. No.:
10/442661
Inventors:
Siobhan P. Ellison - Fairfield FL, US
Assignee:
Schering-Plough Corporation - Kenilworth NJ
Pathogenes, Inc. - Fairfield FL
International Classification:
C12P 1/02
C12N 1/14
US Classification:
4352584, 4352581, 435171, 435373, 424 935, 424 937
Abstract:
The invention relates to a method of excysting and growing protozoal oocysts by in vitro tissue culture resulting in production of a continuous culture of merozoites. The invention also provides an economical and reliable supply of cultured sp. for vaccine production, assays and research. Domesticated that have been vaccinated using the provied sp. are also provided.

Detection Of Sarcocystis Neurona

View page
US Patent:
7273709, Sep 25, 2007
Filed:
Aug 10, 2004
Appl. No.:
10/916046
Inventors:
John B. Dame - Gainesville FL, US
Siobhan P. Ellison - Fairfield FL, US
Charles A. Yowell - Gainesville FL, US
Assignee:
Univeristy of Florida Research Foundation, Inc. - Gainsville FL
International Classification:
G01N 33/53
A61K 39/002
C12P 21/04
C07H 21/04
US Classification:
435 71, 435 697, 435 7021, 536 234, 514 44, 4242691, 4242651, 4241841
Abstract:
A gene encoding a 29 kilodalton protein found on the surface of merozoite stage has been cloned and sequenced. The protein encoded by this gene, termed SnSAG-1, is an immunodominant antigen recognized on protein blots. Methods for using nucleic acids and polypeptides relating to SnSAG-1 in diagnostic tests and vaccine development are disclosed.

Methods For The In Vitro Culture Of Sp. And Uses Thereof

View page
US Patent:
7816118, Oct 19, 2010
Filed:
May 29, 2007
Appl. No.:
11/754498
Inventors:
Siobhan P. Ellison - Fairfield FL, US
Assignee:
Schering-Plough Corporation - Kenilworth NJ
Pathogenes, Inc. - Fairfield FL
International Classification:
C12P 1/02
C12N 1/14
US Classification:
4352584, 4352581, 435171, 435373, 424 935, 424 937
Abstract:
The invention relates to a method of excysting and growing protozoal oocysts by in vitro tissue culture resulting in production of a continuous culture of merozoites. The invention also provides an economical and reliable supply of cultured sp. for vaccine production, assays and research. Domesticated avians that have been vaccinated using the provied sp. are also provided.

Animal Model For Infection By An Apicomplexan Parasite

View page
US Patent:
20030219381, Nov 27, 2003
Filed:
May 22, 2002
Appl. No.:
10/152960
Inventors:
Siobhan Ellison - Fairfield FL, US
International Classification:
A61K049/00
C12N001/10
US Classification:
424/009200, 435/258100
Abstract:
An animal model for CNS infection by Apicomplexan parasites was produced by inoculating a homologous cell or other type of cell with the merozoite stage of the Apicomplexan parasite and inoculating the infected homologous cell or a cell line prepared therefrom back into the host from which it came. Such a model was used to develop drugs for treatment or prophylaxis, vaccines for protection from Apicomplexan diseases and diagnostic tests for determination active infection with Apicomplexan parasites.

Definitive Diagnosis Of Epm In The Horse

View page
US Patent:
20060073524, Apr 6, 2006
Filed:
Sep 20, 2002
Appl. No.:
10/251567
Inventors:
Siobhan Ellison - Fairfield FL, US
International Classification:
G01N 33/569
G01N 33/53
US Classification:
435007220
Abstract:
The present invention concerns detection of acute, chronic, or sub-acute equine protozoal myeloencephalitis by detecting antibodies in serum or CSF or the lymphoblastogenesis response to a recombinant protein that is folded in a conformationally correct state and is the immunodominant surface antigen of

Induction Of A Parasitemia And Preventing Neuroinflammation By Binding Cholinergic Receptors In Apicomplexan Infections Using Levamisole Hcl

View page
US Patent:
20150338394, Nov 26, 2015
Filed:
May 20, 2014
Appl. No.:
14/120462
Inventors:
William T. Killeen - Fairfield FL, US
Siobhan Ellison - Fairfield FL, US
International Classification:
G01N 33/50
Abstract:
Equine protozoal myeloencephalitis (EPM) is the most commonly diagnosed infectious neuro-degenerative in horses. Important advances have been made in the biology of but little attention has been paid to the inflammatory component of disease although neuroinflammation is present in all definitively diagnosed cases of EPM. Polyneuritis equi (cauda equina neuritis) of horses is a rarely recognized non-infectious, chronic relapsing, peripheral neurodegenerative disorder in horses. We propose that polyneuritis equi may be associated with infections. We demonstrate the presence of serum antibodies against myelin proteins and surface antigens in 78% (n=55) ataxic horses with a presumptive diagnosis of EPM. Serum antibodies against were detected in a horse with histopathologically confirmed polyneuritis equi, also sarcocysts were observed by histopathology. A clinical response to levamisole HCl treatment in ataxic horses may support cytokine mediated mechanism of the neuropathy.
Siobhan P Ellison from Reddick, FL, age ~72 Get Report